Channel Growth Levo System can be expanded through audiology clinics, ENT practices, and hospital partner networks. With a very small internal team, leveraging established distributors and contract partnerships could accelerate market access without heavy headcount growth. The company has shown willingness to scale its sales organization with a leadership hire in the past, suggesting room for continued sales expansion. Recommend engaging regional audiology distributors and implementing partner-driven sales programs to build field momentum.

Partnerships and OEMs In a competitive tinnitus device landscape, pursue strategic partnerships or OEM licensing with hearing aid manufacturers and medical device distributors to scale reach for Levo. This approach provides access to existing patient channels and service networks while maintaining Otoharmonics' brand and control.

Digital Marketing The existing digital marketing stack indicates commitment to online reach; optimize lead generation by integrating a CRM, improving attribution, and pursuing account-based marketing toward ENT clinics and audiology groups. Develop clinician-focused content, webinars, and patient testimonials to shorten sales cycles and increase conversion.

Investment Readiness The company is at an early growth stage with room to expand; present a clear ROI case for partners and potential investors. Build a data package with unit economics, payback considerations, clinical outcomes, and case studies to support partnership discussions and potential funding opportunities.

Differentiation Expansion Levo's personalized sound therapy and user-friendly design align with trends in noninvasive tinnitus management; emphasize clinical outcomes, patient engagement features, and ease of use to differentiate from larger competitors. Explore adjacent opportunities such as sleep-related therapy or cognitive tinnitus management and secure endorsements from key opinion leaders to accelerate adoption.